Home Services Results Insights About FAQ Book a Call
Insights · Guide

What Medicare Advantage Denials Really Cost Hospitals

New OIG data on Medicare Advantage points to two separate revenue leaks for hospitals: bed-days spent on stays extended by denied placements, and denials nobody ever appeals. They need two different fixes, and neither is a bigger billing team.

$48.4B
Hospital revenue lost to denials industry-wide in 2025
2 in 3
Denied patients who never appeal, per new OIG data
90%
Of denials are estimated to be preventable

Two new OIG reports on Medicare Advantage prior authorization got covered as a clinical story. For a hospital's revenue cycle, it's really two separate financial stories layered on top of each other: the cost of a bed that keeps being occupied after a placement gets denied, and the cost of a denial nobody ever challenges. Both are avoidable, and neither is fixed by working the appeals desk harder.

Cost One: The Bed Nobody's Fully Paying For

When Medicare Advantage denies a patient's next placement — a skilled nursing facility, a long-term acute care bed, an inpatient rehab admission — the patient stays in the acute hospital bed instead. OIG found Medicare Advantage organizations overturned 95% of appealed skilled nursing facility denials, and across 19 organizations reviewed for long-term acute care and rehabilitation, CVS Health Corp. denied 80% of long-term acute care admission requests — the highest rate evaluated[1]. Every one of those denials, while it's being sorted out, is a bed the hospital is staffing and managing without the reimbursement structure of a planned, medically-necessary acute stay.

Cost Two: The Two-Thirds Who Never Appeal

In the same long-term care and rehabilitation review, only about a third of denied patients ever filed an appeal[1]. Apply the overturn rates above to the two-thirds who don't, and the math is uncomfortable: if appealed cases win 36% to 95% of the time depending on the category, there's no reason the unappealed cases were decided any more fairly — they simply never got the chance. For a hospital, that's a stack of denials tied to care and bed-days already delivered that will never be paid, not because the denial was correct, but because nobody had the documentation ready inside the appeal window.

Why Hospitals Under-Appeal

It's rarely a judgment call to skip an appeal — it's a capacity problem. Appeals require a clean, payor-aligned clinical packet assembled and submitted inside a tight eligibility window, on top of every other case an already-stretched UM and appeals team is carrying. When that packet isn't ready in time, the appeal doesn't happen, whether or not the underlying denial was legitimate. See How Hospitals Reduce Denial Rates for what a fast, complete appeals process actually requires.

The Fix Costs Less Than Either Problem

Neither leak gets solved by appealing harder after the fact. The bed-day cost is contained by daily concurrent review that keeps the acute stay's documentation current for as long as a placement is pending — see Concurrent Review, Explained. The unappealed-denial cost is contained by having appeals-ready documentation built in from the start, so a denial worth challenging never misses its window in the first place.

"Every denial prevented at the front end is far more valuable than a denial appealed on the back end."

That's the same principle behind Hospital 1's results with bServed: a 43% drop in denials alongside a 10X verified ROI — driven by prevention during the stay, not a faster appeals desk. See the full case study, or every result on the Results page.

← Back to All Insights

Ready to See Results Like This?

Schedule a free audit and find out exactly where your hospital is losing revenue.

Request a Free Audit →
bServed © 2026 bServed. All rights reserved.